ArticleImmunoHorizons2026
Identification of genetic variants in B cell expressed genes associated with systemic lupus erythematosus in African American females.
Article in ImmunoHorizons, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by dysregulated B cell responses and pathogenic autoantibody production. Given the central role that B cells play in SLE pathogenesis, we aimed to characterize genetic variation within the B cell compartment of African ancestry (AFR) women with SLE who are disproportionately and more severely affected by SLE. Here, we analyzed RNA-seq data from a previously published study of high disease activity AFR SLE individuals and healthy controls (HC) to identify coding variants in B cells with potential functional consequence that may underpin disease. In this cohort, we identified 575 missense variants associated with 158 unique genes. While many variant-containing genes did not exhibit large transcriptional changes between cohorts, a subset occurred within genes involved in B cell signaling, activation, and differentiation. However, genes enriched in AFR SLE were consistently upregulated across multiple B cell subtypes, suggesting that variant-associated transcriptional changes occur broadly across the B cell compartment and not within a single subset. Among these, the TNFAIP3 variant rs2230926 was enriched in AFR SLE individuals and occurs at a substantially higher allele frequency in AFR populations. This study provides insights into genetic variation found within the B cell compartment that may contribute to immune dysregulation and disease pathogenesis in SLE in AFR populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.